Pfizer aims to sell over-the-counter version of Lipitor

A clinical trial due to be completed by year-end will determine whether Pfizer applies for U.S. regulatory approval for Lipitor to become the first OTC version of a statin.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.